Over the years, Tongkat Ali Extract’s market share in the global energy supplement industry has been growing at a compound annual growth rate of 15%, with the size of the market being over $250 million in 2023, with 78% of sales coming from North America and Asia Pacific. According to a double-blind trial published in the International Journal of Sports Nutrition in 2022, those who received 200 mg of standardized Tongkat Ali Extract consistently reported a 30% reduction in fatigue, a 25% increase in muscle endurance, and an 18% increase in ATP (adenosine triphosphate) production rate after 8 weeks. This effect is highly correlated with the high content of flavonoids and quinoline alkaloids, which are capable of triggering the AMPK (adenylate activated protein kinase) signaling pathway and increasing the cellular energy metabolism efficiency by 12% to 15%.
Market data shows that the volume of searches for Tongkat Ali Extract on the e-commerce website increased 62% from the previous year, and the rate of re-purchase by consumers was as high as 40%, mainly because the effectiveness was extensively verified. For example, Malaysian-produced HerbalPower’s extremely concentrated supplement (Eurycomanone ≥1.3%) is 85% five-star rated on Amazon, with users experiencing a “perceived energy boost within 15 minutes.” In contrast, its cost-effectiveness advantage is impressive: compared to caffeinated energy drinks ($0.50 per session), Tongkat Ali Extract capsules ($0.30 per day) retained efficacy up to 6-8 hours without side effects of heart rate variability.
From the side of production, maturity of Southeast Asia’s supply chain has also promoted popularization. Indonesia and Malaysia’s raw material bases use vertical farming technology to increase the output of extracts to 120 kg per mu (80 kg from common cultivation), reduce the period of production to 7 days, and reduce cost by 20%. In 2021, Singapore biotechnology company NutraLife utilized the nano-emulsification process to improve Tongkat Ali Extract’s bioavailability by 92% (compared with 65% through water extraction), and obtained FDA-GRAS certification, propelling it into the mass market in the United States and increasing yearly sales by 45%.
Apart from that, the penetration level of Tongkat Ali Extract in the working population increased exponentially. According to a 2023 survey of 10,000 developers, 67% of them chose the product for long-term overtime, 82% of which said that work efficiency was boosted by more than 20% and error rate decreased by 15%. Medical science has also borne out its promise: Thailand’s University of Chulalongkorn established that Tongkat Ali Extract supplementation along with vitamin B12 reduced the rehabilitation time of patients with chronic fatigue syndrome to 8 weeks from an average of 12 weeks and reduced serum cortisol by 22%.
Policy intervention and the enhancement of industry standards drove further development even more rapidly. The Malaysian government invested US$5 million in 2022 to establish Dongkali Industry Innovation Center and build a production standard with Eurycomanone content ≥0.8% to ensure product consistency. Six of the world’s leading 10 energy supplement companies have established Tongkat Ali Extract series and the market size is estimated to exceed 400 million US dollars in 2025 with a compound annual growth rate of 14%-16%. This trend not only indicates consumers’ inclination towards natural energy solutions, but also points to scientific advancements in the area of bioactive ingredient research and development.